Comparatively, obesity rates in most European countries remain below 25 percent, with some nations, particularly in Southern ...

Obesity extends far beyond carrying extra weight - it represents a chronic condition affecting millions globally. While ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

Dr. Cheryl Kendall discusses urgent pediatric health concerns, offering solutions for childhood obesity and digital addiction ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

British patients with obesity undergoing hip and knee replacements had less of a need for subsequent revision when, after surgery, they lost weight by using medications such as GLP-1 receptor agonists ...

Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...

Eli Lilly wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in ...

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...